Valuation

ServiceTitan (TTAN) Stock: After a Volatile Month, Is the Price Finally Attractive?
Business

ServiceTitan (TTAN) Stock: After a Volatile Month, Is the Price Finally Attractive?

ServiceTitan shares have been on a rollercoaster—up 14% in the past month but down 13.7% over the past week and roughly 34% year to date. With the stock trading at $66.77, investors are questioning whether the dip presents a buying opportunity or if more downside remains. This article examines the valuation through two lenses: a discounted cash flow analysis that suggests the stock is undervalued, and a price-to-sales comparison that flags it as overpriced.

Nokia Stock Surges 127% YTD: Is the Rally Justified?
Business

Nokia Stock Surges 127% YTD: Is the Rally Justified?

Nokia Oyj (NYSE:NOK) has seen its share price rocket 127% year to date, closing at US$14.80. But with valuations now pointing to a potential overvaluation of 18%, investors are questioning whether the rally has outpaced fundamentals. This article examines the key drivers behind the surge and what the numbers say about Nokia's fair value.

Okta’s AI Identity Pivot Reshapes Growth and Valuation Outlook
Business

Okta’s AI Identity Pivot Reshapes Growth and Valuation Outlook

Okta is deepening its push into AI-driven identity management as new agent-focused solutions gain traction with enterprise customers. The company’s stock has rebounded sharply over the past month, but analysts remain split on whether the AI narrative justifies the current valuation. With rising bookings from AI agent identity products and solid core revenue growth, the debate now centers on execution and competitive positioning.

TTM Technologies Shares Surge on Record Q1 Results, But Valuation Questions Loom
Business

TTM Technologies Shares Surge on Record Q1 Results, But Valuation Questions Loom

TTM Technologies posted record first-quarter fiscal 2026 results, fueled by robust data center demand and a hefty aerospace & defense backlog. The stock has rallied 27.45% in the past month and 168.97% year-to-date, yet it now trades above the analyst fair value of $170, raising concerns that future growth may already be priced in. This article explores the balance between continued momentum and emerging risks.

Royal Gold Restructures Hod Maden Stake, Shifts to Royalty Model Amid Share Price Dip
Business

Royal Gold Restructures Hod Maden Stake, Shifts to Royalty Model Amid Share Price Dip

Royal Gold (RGLD) has restructured its involvement in Turkey's Hod Maden project by reducing its equity stake and adding a new royalty stream, a move that alters its risk profile and cash flow outlook. The stock has fallen 23.52% over 90 days and 12.71% over 30 days, though long-term returns remain strong at 23.05% (1-year) and 88.73% (5-year). Trading at $220.29—well below a modeled fair value of $336.17—the shares appear undervalued. However, a P/E of 29.5x exceeds the metals and mining industry average, limiting downside protection. The analysis explores growth assumptions, margin expectations, and key risks including gold price support and project delays.

EMA Backs Wegovy Oral Pill, Reigniting Novo Nordisk Valuation Debate
Business

EMA Backs Wegovy Oral Pill, Reigniting Novo Nordisk Valuation Debate

The European Medicines Agency’s positive opinion on Wegovy’s oral pill has rekindled investor interest in Novo Nordisk, especially in the obesity and cardiovascular space. Despite a sharp short-term recovery—up 11.18% in 30 days and 18.61% in 90 days—year-to-date returns remain negative at -12.49%, and one-year total shareholder return has fallen 34.31%. With the stock trading at DKK289 against a fair value estimate of DKK851.04 per share, the question is whether this gap reflects genuine upside or expectations already baked in.

Broadcom's Record Q2 Revenue Fails to Lift Stock as AI Guidance Triggers Pullback: Is the Valuation Gap Widening?
Business

Broadcom's Record Q2 Revenue Fails to Lift Stock as AI Guidance Triggers Pullback: Is the Valuation Gap Widening?

Broadcom (AVGO) reported record Q2 revenue of $22.19 billion and net income of $9.31 billion, yet shares fell as investors reacted to cautious next-quarter guidance and shifting sentiment around AI chips. Despite the pullback, the stock remains up nearly 10% year-to-date, and a significant valuation gap persists—with the current price well below analyst fair value estimates.